Ascendis Pharma A/S Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities
Ascendis Pharma A/S (ASND) reported Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities of -EUR 99.18 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities · last filed 2026-02-11
| Period end | Increase Decrease Through Effect Of Changes In Foreign Exchange Rates Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2025-12-31 | -99.18M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 49.66M EUR 20-F · filed 2026-02-11 |
| 2023-12-31 | -21.25M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 20.05M EUR 20-F · filed 2024-02-07 |
| 2021-12-31 | 6.53M EUR 20-F · filed 2023-02-16 |